World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
18585
World Ranking
19666
National Ranking
9795

Overview

Daniel C. Ihde was affiliated with the National Institutes of Health in the United States during their research career. Their work was situated within the biomedical and health sciences environment characteristic of this institution.

There are no specific records of recent papers, co-authors, or publication venues associated with Daniel C. Ihde in the available data.

There are also no detailed records of book publications or defined main or subfields of study that can be attributed to this scientist.

The absence of listed main topics, awards, and recognitions in the provided data limits further detail on specific areas of expertise or distinctions received during their career.

The scientist is noted as deceased.

Best Publications

  • A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

    Jean Pierre Pignon;Rodrigo Arriagada;Daniel C. Ihde;David H. Johnson

  • CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival.

    John L. Nugent;Paul A. Bunn;Mary J. Matthews;Daniel C. Ihde

  • A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.

    Kaye Fj;Bunn Pa;Steinberg Sm;Stocker Jl

  • Chemotherapy of Lung Cancer

    Daniel C. Ihde

  • Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

    D L Longo;P L Duffey;R C Young;S M Hubbard

  • Recombinant Leukocyte A Interferon: An Active Agent in Advanced Cutaneous T-Cell Lymphomas

    Paul A. Bunn;Kenneth A. Foon;Daniel C. Ihde;Dan L. Longo

  • NCI-Navy Medical Oncology Branch cell line data base

    Ruby M. Phelps;Bruce E. Johnson;Daniel C. Ihde;Adi F. Gazdar

  • myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

    B E Johnson;D C Ihde;R W Makuch;A F Gazdar

  • Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups

    Edward A. Sausville;Joyce L. Eddy;Robert W. Makuch;A. B. Fischmann

  • Staging and prognostic factors in small cell lung cancer: a consensus report

    Rolf Arno R. Stahel;Robert Ginsberg;Klaus Havemann;Fred R Hirsch

  • Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer: A Prospective, Randomized Trial

    P. A. Bunn;A. S. Lichter;R. W. Makuch;M. H. Cohen

  • Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.

    D L Longo;V T DeVita;P L Duffey;M N Wesley

  • Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.

    D C Ihde;J L Mulshine;B S Kramer;S M Steinberg

  • Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers.

    G E Richardson;M A Tucker;D J Venzon;R I Linnoila

  • Clinical trials in primary hepatocellular carcinoma: current status and future directions.

    Stacy R. Nerenstone;Daniel C. Ihde;Michael A. Friedman

  • Small cell lung cancer 1973-1983: Early progress and recent obstacles

    George Morstyn;Daniel C. Ihde;Allen S. Lichter;Paul A. Bunn

  • MDR1 Gene Expression in Lung Cancer

    Shinn Liang Lai;Lori J. Goldstein;Michael M. Gottesman;Ira Pastan

  • A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

    R F Ozols;D C Ihde;W M Linehan;J Jacob

  • Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.

    M. H. Cohen;D. C. Ihde;P. A. Bunn;B. E. Fossieck

  • The clinical behavior of „mixed”︁ small cell/large cell bronchogenic carcinoma compared to „pure”︁ small cell subtypes

    Peter A. Radice;Mary J. Matthews;Daniel C. Ihde;Adi F. Gazdar

Frequent Co-Authors

John D. Minna
John D. Minna The University of Texas Southwestern Medical Center
Adi F. Gazdar
Adi F. Gazdar The University of Texas Southwestern Medical Center
Bruce E. Johnson
Bruce E. Johnson Harvard University
Paul A. Bunn
Paul A. Bunn University of Colorado Boulder
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Eli Glatstein
Eli Glatstein University of Pennsylvania
Dan L. Longo
Dan L. Longo Harvard University
David Venzon
David Venzon National Institutes of Health
Vincent T. DeVita
Vincent T. DeVita Yale University
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the medical field beyond the traditional MD pathway, there are a variety of flexible online degree options. These programs can broaden your career prospects and allow you to advance your education while balancing work or family commitments.

Advancing nurses can consider the best dnp programs online to gain leadership roles and improve patient care. Those interested in pharmaceuticals can enroll in pharm d online programs to become licensed pharmacists and healthcare providers.

If you prefer working with data and systems, an online health information management degree can lead to in-demand roles in health informatics and administration. Meanwhile, those looking for a quicker pathway into the healthcare sector might benefit from medical coding certification online, opening doors to remote medical billing and coding positions.

These online programs offer a range of opportunities whether you seek patient-facing roles, management, pharmacy, or health information careers.

Best Scientists Citing Daniel C. Ihde